Pharmaceutical

EC approves AbbVie’s Tepkinly combination for follicula...

The decision is based on data from the pivotal Phase III EPCORE FL-1 trial, whic...

Lessons from the Delhi–Agra–Puducherry counterfeit medi...

Introduction India is often described as the “pharmacy of the world.” Yet, the ...

Novartis to acquire Myricx Bio in up to $1.5bn deal

The deal includes an upfront payment of $1.1bn and up to $400m in potential mile...

Besins Healthcare boosts drug delivery portfolio with U...

UniD Manufacturing’s expertise includes advanced polymer systems used in complex...

Immuneel and Arogya Finance launch India’s first zero c...

Immuneel Therapeutics, India’s pioneering cell and gene therapy  company, annou...

FOPE seeks CDSCO clarification on pharmacovigilance obl...

The Federation of Pharma Entrepreneurs (FOPE) has sought clarifications from th...

The fine line between reform and risk 

A couple of recent notifications, one a notified amendment and the second one, ...

European Commission approves Novartis’ Itvisma to treat...

With this decision, Itvisma becomes the only gene replacement therapy which is c...

SK bioscience to lead Gates Foundation-funded ROTOR pro...

The project will involve collaboration with global health organisation PATH and ...

Centre amends Drugs Rules, 1945 to ensure uniform regul...

The Central Government has amended the Drugs Rules, 1945 to bring cell or stem ...

ABB’s Machine Automation division appoints Pratip Saman...

B&R, ABB’s Machine Automation division, announced the appointment of Pratip Sam...

Shantha Biologics, Novo Nordisk collaborate for cartrid...

No financial terms or further details of the agreement were disclosed. The post...

DoP amends DPCO 2013 to ease compliance, clarify overch...

The Department of Pharmaceuticals (DoP) has notified the Drugs (Prices Control)...

From packaging to patient outcomes: Why India’s latest ...

The pharmaceutical industry has traditionally regarded packaging as the final s...

Insilico Medicine, Takeda partner on AI-driven drug dis...

Under the agreement, Insilico will lead efforts using AI to identify molecules t...

Inocras, AimedBio team up for cancer treatments

The deal includes a strategic equity investment by AimedBio in Inocras and a joi...